Company intelligence
Diapath - A StatLab Company
Constant Innovation in Anatomic Pathology
About Diapath - A StatLab Company
Innovating Pathology Essentials. Together. Part of the StatLab family of companies, Diapath S.p.A. is dedicated to redefining excellence in anatomic pathology, empowering laboratories and hospitals worldwide to deliver the highest standards of patient care. With decades of expertise, Diapath designs, manufactures, and distributes a comprehensive portfolio of instruments, reagents, and consumables for histology and cytology. Our fully integrated approach ensures complete control over quality, reliability, and innovation, all developed and tested at our Italian headquarters. Driven by a passion for continuous improvement, we invest in research and development to create safer, smarter, and more efficient solutions for laboratory professionals. Every product is crafted with the operator in mind, because the sample is unique, as you are. As part of a global organization, Diapath combines Italian design and precision with StatLab’s worldwide reach and expertise. Together, we innovate pathology essentials, delivering precision, safety, and care in every detail.
Verified activity
Signals from Diapath - A StatLab Company
4 published signals
Products & Services
Diapath - A StatLab Company launched a new website redesign featuring streamlined navigation, direct product information, and an enhanced Private Area.
Reported by Diapath - A StatLab Company
Products & Services
Diapath - A StatLab Company launched a new official website to showcase its solutions, simplify access to information, and strengthen connections with the anatomic pathology community.
Reported by Laura Vavassori
Presence & Recognition
Diapath - A StatLab Company is hosting a new webinar titled Diapath Lab Talks 2026 featuring an expert-led presentation by MD PhD Konrad Steinestel on neoplastic lung pathology.
Reported by Diapath - A StatLab Company
Presence & Recognition
Diapath - A StatLab Company is hosting a Diapath Lab Talks Webinar titled Current concepts in neoplastic lung pathology on September 24 and 25, 2026.
Reported by Laura Vavassori